Screener
Insmed INSM Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Insmed in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Insmed’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104506-26-000032
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Provision for income taxes | 1,465 | 912 |
| Net loss | $(163,563) | $(256,583) |
| Basic and diluted net loss per share | $(0.76) | $(1.42) |
| Weighted average basic and diluted common shares outstanding | 215,468 | 180,860 |
| Net loss | $(163,563) | $(256,583) |
| Other comprehensive income (loss): | ||
| Foreign currency translation (losses) gains | (668) | 1,828 |
| Unrealized loss on marketable securities | (789) | (441) |
Item 1C. Consolidated Financial Statements
FAQ
- What is Insmed's shares (diluted)?
- Insmed (INSM) reported shares (diluted) of 215.5M in Q1 2026.
- How has Insmed's shares (diluted) changed year-over-year?
- Insmed's shares (diluted) increased by 19.1% year-over-year, from 180.9M to 215.5M.
- What is the long-term trend for Insmed's shares (diluted)?
- Over 4 years (2021 to 2025), Insmed's shares (diluted) has grown at a 15.3% compound annual growth rate (CAGR), from 441.8M to 780.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Insmed's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude